Propafenone Hydrochloride Tablet, Film Coated
Product Images NDC 64380-246
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Propafenone Hydrochloride (NDC 64380-246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Draft-cont-label (E3779c96 A513 4375 857e Bbe3b2532d64 02)
Each tablet contains 150 mg of Propafenone HCl. Manufactured by Strides Pharma Science Limited in India, the tablets are distributed by Strides Pharma Inc. The usual adult dosage and other relevant information can be found in the package insert. It is recommended to store the tablets in a tight, light-resistant container at 20-25°C (68-77°F) as per USP guidelines. Patient Information Leaflet available at www.strides.com/prop-hcl-tabs-2/.*
Cont-label-225mg (E3779c96 A513 4375 857e Bbe3b2532d64 03)
Each tablet contains 225 mg of Propafenone HCI. The usual adult dosage should be referred to the package insert. Remember to keep this medication out of reach of children and store it in a tight, light-resistant container within the recommended temperature range. This medication is distributed by Strides Pharma Inc. in East Brunswick, NJ and manufactured by Strides Pharma Science Limited in Bengaluru, India.*
Propa-cont-300mg (E3779c96 A513 4375 857e Bbe3b2532d64 04)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.